QA: LEAP THERAPEUTICS INC. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001509745_2023_LEAP_THERAPEUTICS_INC.pdf

Logs

info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001509745, LEAP THERAPEUTICS INC.

  xvar xval
0 AssetsCurrent 67,950,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 20,000
3 remainder_Assets 2,383,000
4 LiabilitiesCurrent 11,225,000
5 LiabilitiesNoncurrent 262,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,798,000
9 ResearchAndDevelopmentExpense 44,965,000
10 remainder_Expenses 201,000
11 remainder_Revenues 2,051,000
12 remainder_NetIncome 317,000
13 remainder_ComprehensiveNetIncome 395,000
  yvar yval
0 Assets 70,353,000
1 Liabilities 11,487,000
2 Expenses 56,964,000
3 Revenues 2,051,000
4 StockholdersEquity 58,866,000
5 NetIncome -54,596,000
6 ComprehensiveNetIncome -54,398,500
7 BaseVar 70,783,500
8 EconomicCapitalRatio 1.14

Edgar->Model Mapping

Feature Distribution

Change over Time